Inovio Pharmaceuticals Net Income 2006-2019 | INO

Inovio Pharmaceuticals net income from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

Inovio Pharmaceuticals Annual Net Income (Millions of US $)
2018	$-97
2017	$-88
2016	$-74
2015	$-29
2014	$-36
2013	$-66
2012	$-20
2011	$-15
2010	$-18
2009	$-24
2008	$-13
2007	$-11
2006	$-14
2005	$-26

Inovio Pharmaceuticals Quarterly Net Income (Millions of US $)
Q1 2019	$-29
Q4 2018	$-33
Q3 2018	$-25
Q2 2018	$-7
Q1 2018	$-32
Q4 2017	$-22
Q3 2017	$-34
Q2 2017	$-9
Q1 2017	$-23
Q4 2016	$-26
Q3 2016	$-21
Q2 2016	$-19
Q1 2016	$-8
Q4 2015	$-18
Q3 2015	$6
Q2 2015	$-6
Q1 2015	$-11
Q4 2014	$-7
Q3 2014	$-7
Q2 2014	$-11
Q1 2014	$-11
Q4 2013	$-15
Q3 2013	$-31
Q2 2013	$-11
Q1 2013	$-9
Q4 2012	$-1
Q3 2012	$-7
Q2 2012	$-4
Q1 2012	$-8
Q4 2011	$-5
Q3 2011	$-5
Q2 2011	$-3
Q1 2011	$-2
Q4 2010	$-6
Q3 2010	$-1
Q2 2010	$-8
Q1 2010	$-2
Q4 2009	$-7
Q3 2009	$-3
Q2 2009	$-11
Q1 2009	$-3
Q4 2008	$-4
Q3 2008	$-2
Q2 2008	$-4
Q1 2008	$-3
Q4 2007	$-1
Q3 2007	$-3
Q2 2007	$-4
Q1 2007	$-4
Q4 2006	$-8
Q3 2006	$-3
Q2 2006	$-3
Q1 2006
Q4 2005	$-12
Q3 2005	$-3
Q2 2005	$-2
Q1 2005	$-9

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$0.294B	$0.030B
Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. Inovio's clinical programs include human papillomavirus (HPV)/cervical cancer (therapeutic), avian influenza (preventative), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) vaccines. It is advancing preclinical research for a universal seasonal/pandemic influenza vaccine. The Company's partners and collaborators include University of Pennsylvania, National Microbiology Laboratory of the Public Health Agency of Canada, NIAID, Merck, ChronTech, University of Southampton, and HIV Vaccines Trial Network. Inovio Pharmaceuticals, Inc. is headquartered in Blue Bell, Pennsylvania.

Stock Name	Country	Market Cap	PE Ratio
Amgen (AMGN)	United States	$108.245B	12.24
Gilead Sciences (GILD)	United States	$85.342B	10.36
Celgene (CELG)	United States	$64.552B	10.94
Vertex Pharmaceuticals (VRTX)	United States	$45.118B	54.54
Biogen (BIIB)	United States	$44.896B	8.52
Illumina (ILMN)	United States	$44.438B	51.50
CSL (CSLLY)	Australia	$35.409B	0.00
Regeneron Pharmaceuticals (REGN)	United States	$32.605B	15.32
Actelion (ALIOF)	Switzerland	$29.891B	0.00
Alexion Pharmaceuticals (ALXN)	United States	$27.541B	15.59
Incyte (INCY)	United States	$17.129B	69.46
Exact Sciences (EXAS)	United States	$14.845B	0.00
BioMarin Pharmaceutical (BMRN)	United States	$14.750B	0.00
SINO PHARMACEUT (SBMFF)	China	$14.154B	0.00
Sarepta Therapeutics (SRPT)	United States	$11.364B	0.00
Genmab (GNMSF)	Denmark	$11.067B	56.26
Array BioPharma (ARRY)	United States	$10.346B	0.00
Seattle Genetics (SGEN)	United States	$10.192B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$9.283B	49.21
QIAGEN (QGEN)	Netherlands	$8.908B	29.26
Galapagos (GLPG)	Belgium	$8.802B	0.00
Bio-Techne Corp (TECH)	United States	$7.964B	54.34
Alnylam Pharmaceuticals (ALNY)	United States	$7.909B	0.00
Guardant Health (GH)	United States	$7.720B	0.00
Bluebird Bio (BLUE)	United States	$7.368B	0.00
Amarin (AMRN)	Ireland	$7.189B	0.00
Exelixis (EXEL)	United States	$6.482B	16.52
BeiGene (BGNE)	Cayman Islands	$5.652B	0.00
Ascendis Pharma (ASND)	Denmark	$4.867B	0.00
ARGENX SE-ADR (ARGX)	Netherlands	$4.719B	0.00
Moderna (MRNA)	United States	$4.652B	0.00
Blueprint Medicines (BPMC)	United States	$4.628B	0.00
Horizon Pharma Public (HZNP)	Ireland	$4.408B	11.35
Repligen (RGEN)	United States	$4.177B	104.05
ACADIA Pharmaceuticals (ACAD)	United States	$3.787B	0.00
Spark Therapeutics (ONCE)	United States	$3.752B	0.00
Mirati Therapeutics (MRTX)	United States	$3.729B	0.00
China Biologic Products (CBPO)	China	$3.682B	23.39
Alkermes (ALKS)	Ireland	$3.668B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$3.401B	0.00
MorphoSys AG (MOR)	Germany	$3.316B	0.00
Arena Pharmaceuticals (ARNA)	United States	$3.062B	6.22
Amicus Therapeutics (FOLD)	United States	$2.899B	0.00
Immunomedics (IMMU)	United States	$2.772B	0.00
Medicines (MDCO)	United States	$2.740B	0.00
UniQure (QURE)	Netherlands	$2.631B	0.00
Reata Pharmaceuticals (RETA)	United States	$2.613B	0.00
CRISPR Therapeutics AG (CRSP)	Switzerland	$2.566B	0.00
Halozyme Therapeutics (HALO)	United States	$2.468B	0.00
MyoKardia (MYOK)	United States	$2.308B	0.00
Ligand Pharmaceuticals (LGND)	United States	$2.299B	19.04
Nabriva Therapeutics AG (NBRV)	Ireland	$2.251B	0.00
Emergent Biosolutions (EBS)	United States	$2.231B	19.38
NeoGenomics (NEO)	United States	$2.216B	145.06
Acceleron Pharma (XLRN)	United States	$2.160B	0.00
Zai Lab (ZLAB)	China	$2.106B	0.00
Genomic Health (GHDX)	United States	$2.078B	44.13
Akcea Therapeutics (AKCA)	United States	$2.072B	0.00
Intercept Pharmaceuticals (ICPT)	United States	$2.046B	0.00
Denali Therapeutics (DNLI)	United States	$1.911B	0.00
Myriad Genetics (MYGN)	United States	$1.907B	18.97
REGENXBIO (RGNX)	United States	$1.720B	0.00
Insmed (INSM)	United States	$1.690B	0.00
Cambrex (CBM)	United States	$1.501B	18.98
Fate Therapeutics (FATE)	United States	$1.464B	0.00
AnaptysBio (ANAB)	United States	$1.431B	0.00
RA PHARMCTL INC (RARX)	United States	$1.421B	0.00
Innoviva (INVA)	United States	$1.405B	3.89
Sangamo Therapeutics (SGMO)	United States	$1.349B	0.00
Athenex (ATNX)	United States	$1.329B	0.00
Alector (ALEC)	United States	$1.311B	0.00
Coherus BioSciences (CHRS)	United States	$1.284B	0.00
Editas Medicine (EDIT)	United States	$1.198B	0.00
Orchard Therapeutics (ORTX)	United Kingdom	$1.185B	0.00
Epizyme (EPZM)	United States	$1.174B	0.00
Cara Therapeutics (CARA)	United States	$1.036B	0.00
Codexis (CDXS)	United States	$1.031B	0.00
Adverum Biotechnologies (ADVM)	United States	$1.013B	0.00
Momenta Pharmaceuticals (MNTA)	United States	$1.013B	0.00
Dicerna Pharmaceuticals (DRNA)	United States	$0.979B	0.00
ANI Pharmaceuticals (ANIP)	United States	$0.976B	17.31
Twist Bioscience (TWST)	United States	$0.963B	0.00
Principia Biopharma (PRNB)	United States	$0.955B	0.00
Zymeworks (ZYME)	Canada	$0.940B	0.00
ZIOPHARM Oncology Inc (ZIOP)	United States	$0.928B	0.00
WAVE Life Sciences (WVE)	Singapore	$0.924B	0.00
Retrophin (RTRX)	United States	$0.873B	0.00
Alder BioPharmaceuticals (ALDR)	United States	$0.873B	0.00
BAVARIAN NORDIC (BVNRY)	Denmark	$0.856B	0.00
Vericel (VCEL)	United States	$0.854B	0.00
Arvinas (ARVN)	United States	$0.811B	0.00
Intellia Therapeutics (NTLA)	United States	$0.755B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.712B	33.60
Precision BioSciences (DTIL)	United States	$0.699B	0.00
Zealand Pharma (ZEAL)	Denmark	$0.683B	7.99
Zealand Pharma (ZLDPF)	Denmark	$0.683B	0.00
Clovis Oncology (CLVS)	United States	$0.678B	0.00
Cytokineticsorporated (CYTK)	United States	$0.668B	0.00
Cellectis S.A (CLLS)	France	$0.647B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.640B	0.00
Intra-Cellular Therapies (ITCI)	United States	$0.640B	0.00
Heska (HSKA)	United States	$0.617B	63.16
DBV Technologies S.A (DBVT)	France	$0.604B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.589B	0.00
Anika Therapeutics (ANIK)	United States	$0.579B	19.79
OXFORD BIOMEDCL (OXBDF)	United Kingdom	$0.575B	0.00
Stemline Therapeutics (STML)	United States	$0.568B	0.00
MiMedx (MDXG)	United States	$0.546B	0.00
Revance Therapeutics (RVNC)	United States	$0.542B	0.00
CytomX Therapeutics (CTMX)	United States	$0.537B	0.00
Pharming Group (PHGUF)	Netherlands	$0.521B	0.00
Mesoblast (MESO)	Australia	$0.504B	0.00
PHARMA MAR SA (PHMMF)	Spain	$0.454B	0.00
UROGEN PHARMA (URGN)	United States	$0.447B	0.00
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.442B	0.00
Puma Biotechnology (PBYI)	United States	$0.417B	0.00
Prothena (PRTA)	Ireland	$0.386B	0.00
Biofrontera AG (BFRA)	Germany	$0.385B	0.00
PDL BioPharma (PDLI)	United States	$0.379B	9.06
AC Immune SA (ACIU)	Switzerland	$0.377B	24.26
Arcus Biosciences (RCUS)	United States	$0.376B	0.00
Gritstone Oncology (GRTS)	United States	$0.373B	0.00
Sinovac Biotech (SVA)	China	$0.371B	0.00
Bellus Health (BLUSF)	Canada	$0.366B	0.00
Adaptimmune Therapeutics (ADAP)	United Kingdom	$0.365B	0.00
Scholar Rock Holding (SRRK)	United States	$0.359B	0.00
Avid Bioservices (CDMO)	United States	$0.359B	0.00
Merus (MRUS)	Netherlands	$0.359B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.356B	0.00
Prometic Life Sciences (PFSCD)	Canada	$0.348B	0.00
Albireo Pharma (ALBO)	United States	$0.346B	0.00
Agenus (AGEN)	United States	$0.344B	0.00
Achillion Pharmaceuticals (ACHN)	United States	$0.343B	0.00
BioDelivery Sciences (BDSI)	United States	$0.340B	0.00
Senesco Technologies (ELOX)	United States	$0.337B	0.00
Acorda Therapeutics (ACOR)	United States	$0.331B	5.83
Kadmon Holdings (KDMN)	United States	$0.329B	0.00
Theratechnologies (THERF)	Canada	$0.328B	0.00
Syros Pharmaceuticals (SYRS)	United States	$0.324B	0.00
Protagonist Therapeutics (PTGX)	United States	$0.309B	0.00
Sorrento Therapeutics (SRNE)	United States	$0.308B	0.00
AMAG Pharmaceuticals (AMAG)	United States	$0.304B	0.00
Cellular Biomedicine (CBMG)	United States	$0.270B	0.00
Kindred Biosciences (KIN)	United States	$0.269B	0.00
PHASEBIO PHARMA (PHAS)	United States	$0.263B	0.00
ChromaDex (CDXC)	United States	$0.262B	0.00
Sutro Biopharma (STRO)	United States	$0.261B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$0.260B	0.00
Dynavax Technologies (DVAX)	United States	$0.252B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$0.247B	0.00
Kamada (KMDA)	Israel	$0.238B	9.22
ADMA Biologics Inc (ADMA)	United States	$0.233B	0.00
Athersys (ATHX)	United States	$0.232B	0.00
Geron (GERN)	United States	$0.226B	0.00
Palatin Technologies (PTN)	United States	$0.222B	0.00
Pieris Pharmaceuticals (PIRS)	United States	$0.221B	0.00
Cel-Sci (CVM)	United States	$0.220B	0.00
Cerecor (CERC)	United States	$0.210B	0.00
MannKind (MNKD)	United States	$0.205B	0.00
Five Prime Therapeutics (FPRX)	United States	$0.204B	0.00
Aeglea BioTherapeutics (AGLE)	United States	$0.198B	0.00
CorMedix Inc (CRMD)	United States	$0.198B	0.00
Abeona Therapeutics (ABEO)	United States	$0.196B	0.00
Synlogic (SYBX)	United States	$0.195B	0.00
Mersana Therapeutics (MRSN)	United States	$0.191B	0.00
Affimed (AFMD)	Germany	$0.191B	0.00
OSMOTICA PHARM (OSMT)	United States	$0.186B	0.00
Pfenex (PFNX)	United States	$0.186B	0.00
Spero Therapeutics (SPRO)	United States	$0.185B	0.00
POXEL SA FRANCE (PXXLF)		$0.184B	0.00
Arsanis (XFOR)	United States	$0.183B	0.00
Compugen (CGEN)	Israel	$0.182B	0.00
Enzo Biochem (ENZ)	United States	$0.178B	0.00
BioTime (BTX)	United States	$0.177B	11.80
Newron Pharmaceuticals SpA (NWPHF)		$0.165B	0.00
Nicox SA (NICXF)	France	$0.163B	0.00
XOMA (XOMA)	United States	$0.158B	0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT)	United States	$0.157B	0.00
Strongbridge Biopharma (SBBP)	United States	$0.150B	8.63
OvaScience (MLND)	United States	$0.148B	0.00
Cue Biopharma (CUE)	United States	$0.148B	0.00
TOCAGEN INC (TOCA)	United States	$0.142B	0.00
Liquidia Technologies (LQDA)	United States	$0.140B	0.00
Adocia (ADOCY)	France	$0.140B	0.00
Celyad SA (CYAD)	Belgium	$0.140B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.135B	0.00
Dyadic (DYAI)	United States	$0.134B	0.00
NantKwest (NK)	United States	$0.127B	0.00
Seres Therapeutics (MCRB)	United States	$0.125B	0.00
Aptinyx (APTX)	United States	$0.123B	0.00
Alcobra (ARCT)	United States	$0.120B	0.00
Arbutus Biopharma (ABUS)	Canada	$0.119B	0.00
Aduro Biotech (ADRO)	United States	$0.119B	0.00
AVEO Pharmaceuticals (AVEO)	United States	$0.119B	0.00
Menlo Therapeutics (MNLO)	United States	$0.118B	0.00
Paratek Pharmaceuticals (PRTK)	United States	$0.117B	0.00
Nymox Pharmaceutical (NYMX)	Canada	$0.116B	0.00
Verastem (VSTM)	United States	$0.114B	0.00
Novavax (NVAX)	United States	$0.109B	0.00
ASLAN Pharmaceuticals (ASLN)	Singapore	$0.103B	0.00
Catalyst Biosciences (CBIO)	United States	$0.103B	0.00
Checkpoint Therapeutics (CKPT)	United States	$0.103B	0.00
SESEN BIO, INC (SESN)	United States	$0.100B	0.00
Trevena (TRVN)	United States	$0.097B	0.00
Curis (CRIS)	United States	$0.094B	0.00
Fortress Biotech (FBIO)	United States	$0.093B	0.00
Catabasis Pharmaceuticals (CATB)	United States	$0.085B	0.00
Aridis Pharmaceuticals (ARDS)	United States	$0.084B	0.00
Pluristem Therapeutics (PSTI)	Israel	$0.084B	0.00
Spring Bank Pharmaceuticals (SBPH)	United States	$0.083B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.083B	0.00
VBI Vaccines (VBIV)	United States	$0.082B	0.00
AquaBounty Technologies (AQB)	United States	$0.081B	0.00
Unum Therapeutics (UMRX)	United States	$0.079B	0.00
VTv Therapeutics (VTVT)	United States	$0.078B	0.00
Selecta Biosciences (SELB)	United States	$0.075B	0.00
Merrimack Pharmaceuticals (MACK)	United States	$0.073B	0.00
Idera Pharmaceuticals (IDRA)	United States	$0.073B	0.00
Signal Genetics (MGEN)	United States	$0.072B	0.00
Orgenesis (ORGS)	United States	$0.072B	0.00
Applied Genetic Technologies (AGTC)	United States	$0.069B	37.90
Organovo Holdings (ONVO)	United States	$0.067B	0.00
ARAVIVE, INC (ARAV)	United States	$0.063B	0.00
Sunesis Pharmaceuticals (SNSS)	United States	$0.062B	0.00
Alimera Sciences (ALIM)	United States	$0.062B	0.00
Protalix BioTherapeutics (PLX)	Israel	$0.060B	0.00
Antibe Therapeutics (ATBPF)	Canada	$0.060B	0.00
Prima BioMed (IMMP)	Australia	$0.059B	0.00
Invo BioScience (IVOB)	United States	$0.057B	0.00
NewLink Genetics (NLNK)	United States	$0.054B	0.00
Oncobiologics (OTLK)	United States	$0.053B	0.00
Ophthotech (ISEE)	United States	$0.051B	0.00
Proteostasis Therapeutics (PTI)	United States	$0.050B	0.00